Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06244420

Enrollment

Registered

2024-02-06

Start date

2024-01-10

Completion date

2024-12-31

Last updated

2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoepithelioma

Brief summary

The purpose of the study is to assess whether there is a correlation between imaging and histology with prognosis in patients with soft tissue and bone MC from the archives of the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021

Interventions

OTHERClinical data review

review the medical records, radiological imaging, and histological data of these patients

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan 1998 and 31 Dec 2021 * Age ≥ 2 years old * Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB) * Patients with available clinical and imaging data

Exclusion criteria

* At least one inclusion criterion not met

Design outcomes

Primary

Measure	Time frame	Description
Correlation	At baseline (Day 0)	correlation between imaging and histology with prognosis in patients with soft tissue and bone MC.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026